Fierce Pharma24m
Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant
As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...
Syngene International: Syngene Acquires its First Manufacturing Facility in the US
Expected to enhance global innovator flexibility with biologics drug substance facility in Baltimore BANGALORE, India, March ...